119 related articles for article (PubMed ID: 14522091)
1. High frequency of HLA-B44 allelic losses in human solid tumors.
Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F
Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.
Cabrera CM; López-Nevot MA; Jiménez P; Garrido F
Int J Cancer; 2005 Feb; 113(4):611-8. PubMed ID: 15455354
[TBL] [Abstract][Full Text] [Related]
3. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
[TBL] [Abstract][Full Text] [Related]
4. HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN).
Ozawa A; Sasao Y; Iwashita K; Miyahara M; Sugai J; Iizuka M; Kawakubo Y; Ohkido M; Naruse T; Anzai T; Takashige N; Ando A; Inoko H
Tissue Antigens; 1999 Mar; 53(3):263-8. PubMed ID: 10203019
[TBL] [Abstract][Full Text] [Related]
5. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Cabrera T; Collado A; Fernandez MA; Ferron A; Sancho J; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1998 Aug; 52(2):114-23. PubMed ID: 9756399
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
7. HLA class I antigen and HLA-A, -B, and -C haplotype frequencies in Uruguayans.
Alvarez I; Bengochea M; Toledo R; Carretto E; Hidalgo PC
Hum Biol; 2006 Aug; 78(4):513-25. PubMed ID: 17278625
[TBL] [Abstract][Full Text] [Related]
8. A new HLA-B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5.
Dubois V; Tiercy JM; Labonne MP; Dormoy A; Gebuhrer L
Tissue Antigens; 2004 Feb; 63(2):173-80. PubMed ID: 14705988
[TBL] [Abstract][Full Text] [Related]
9. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
10. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
Koopman LA; Mulder A; Corver WE; Anholts JD; Giphart MJ; Claas FH; Fleuren GJ
Tissue Antigens; 1998 Jun; 51(6):623-36. PubMed ID: 9694355
[TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.
Petersdorf EW; Setoda T; Smith AG; Hansen JA
Tissue Antigens; 1994 Oct; 44(4):211-6. PubMed ID: 7871521
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
[TBL] [Abstract][Full Text] [Related]
15. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
16. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
[TBL] [Abstract][Full Text] [Related]
17. Identification of two major HLA-B44 subtypes and a novel B44 sequence (B*4404). Oligotyping and solid phase sequencing of polymerase chain reaction products.
Yao Z; Keller E; Scholz S; McNicholas A; Volgger A; Albert ED
Hum Immunol; 1995 Jan; 42(1):54-60. PubMed ID: 7751160
[TBL] [Abstract][Full Text] [Related]
18. High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Cabrera T; Angustias Fernandez M; Sierra A; Garrido A; Herruzo A; Escobedo A; Fabra A; Garrido F
Hum Immunol; 1996 Oct; 50(2):127-34. PubMed ID: 8891736
[TBL] [Abstract][Full Text] [Related]
19. HLA-B44 subtypes and the chance of finding HLA compatible donor/recipient pairs for bone marrow transplantation: a haplotype study of 303 Italian families.
Mattiuz PL; Di Paolo E; Fossombroni V; Menicucci A; Pradella F; Porfirio B; Rombolà G
Tissue Antigens; 1997 Dec; 50(6):602-9. PubMed ID: 9458113
[TBL] [Abstract][Full Text] [Related]
20. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
